Dunque, CTI ha conseguito un nuovo brevetto, quello che serve alla preparazione di un particolare acido glutammico. Registrato nel 2010, il brevetto è stato concesso in data 11 dicembre 2012 con il n.8329853 .
La cosa interessante è vedere quanti italiani stanno dietro questo brevetto.
Patent Issued for Process for the Preparation of Poly-.Alpha.-Glutamic Acid and Derivatives
Pharmaceutical Companies NewsRx.comBy a News Reporter-Staff News Editor at Biotech Week --
A patent by the inventors McKennon, Marc (Seattle, WA); Da Re, Giovanni (Milan, IT); Feliciotti, Luca (Sesto San Giovanni, IT); Artico, Marco (Parabiago, IT); Pardi, Gianluca (Ripafratta, IT); Grugni, Mario (Novate, IT), filed on December 10, 2010, was cleared and issued on December 11, 2012, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents (see also Pharmaceutical Companies).
Patent number 8329853 is assigned to Cell Therapeutics, Inc. (Seattle, WA).
The following quote was obtained by the news editors from the background information supplied by the inventors: "The present invention relates to a process for the preparation of poly-.alpha.-glutamic acid and derivatives thereof, and compounds therefrom.
